Anzeige
Mehr »
Dienstag, 11.08.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JLEP | ISIN: US4577301090 | Ticker-Symbol: 2DR
Tradegate
11.08.26 | 19:42
52,00 Euro
0,00 % 0,00
1-Jahres-Chart
INSPIRE MEDICAL SYSTEMS INC Chart 1 Jahr
5-Tage-Chart
INSPIRE MEDICAL SYSTEMS INC 5-Tage-Chart
RealtimeGeldBriefZeit
51,0052,0022:54
51,0051,5021:55

Aktuelle News zur INSPIRE MEDICAL SYSTEMS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
INSPIRE MEDICAL SYSTEMS Aktie jetzt für 0€ handeln
04.08.Inspire Medical surges on revised guidance, earnings, Street upgrade5
04.08.Stifel raises Inspire Medical shares price target on guidance boost2
04.08.KeyBanc reiterates Inspire Medical stock rating after Q2 beat1
04.08.Piper Sandler raises Inspire Medical stock price target on guidance boost1
04.08.RBC raises Inspire Medical shares price target on growth plan1
04.08.Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results14
04.08.Inspire Medical August 2026 slides: $10B market opportunity meets reimbursement reset10
04.08.Inspire Medical Q2 Returns To Profit, Raises FY26 Outlook3
03.08.Inspire Medical posts Q2 beats, raises guidance with new strategic growth plan2
03.08.Inspire Medical Systems Non-GAAP EPS of $0.14 beats by $0.39, revenue of $200.5M beats by $5.89M1
03.08.Inspire Medical Systems, Inc. - 10-Q, Quarterly Report2
03.08.Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan126Generated second quarter revenue of $200.6 millionSecond quarter diluted EPS of $0.01; adjusted diluted EPS of $0.14Second quarter operating cash flow of $23.2 millionAnnounced strategic growth plan...
► Artikel lesen
28.07.UBS initiates Inspire Medical stock with Sell rating on growth concerns1
27.07.Inspire Medical Systems adds AtriCure CEO to board2
27.07.Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors297MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive...
► Artikel lesen
27.07.AtriCure CEO Carrel joins Inspire Medical board of directors2
22.07.Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors269MINNEAPOLIS, July 22, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive...
► Artikel lesen
22.07.Inspire Medical Systems, Inc. - 8-K, Current Report3
06.07.Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 20266
30.06.Inspire Medical: Freedom Capital startet Coverage mit Kaufempfehlung und verweist auf attraktive Bewertung11
Weiter >>
83 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1